Qiu T, Jin Z, Fu Z, Yan X, Zhan C, Zheng H
Open Life Sci. 2025; 20(1):20220971.
PMID: 40059880
PMC: 11889502.
DOI: 10.1515/biol-2022-0971.
Meissner A, Gutsche R, Pennig L, Nelles C, Budzejko E, Hamisch C
Clin Neuroradiol. 2025; .
PMID: 40053087
DOI: 10.1007/s00062-025-01507-6.
Wang R, Zeng Y, Xu J, He M
Front Nutr. 2024; 11:1362817.
PMID: 39036489
PMC: 11257909.
DOI: 10.3389/fnut.2024.1362817.
Jha R, Rajasundaram D, Sneiderman C, Schlegel B, OBrien C, Xiong Z
Neuron. 2024; 112(18):3069-3088.e4.
PMID: 39019041
PMC: 11578855.
DOI: 10.1016/j.neuron.2024.06.021.
Hill-Wall T, McCausland K, Thomas E, Norman R, Bullen J, Cowen G
Concussion. 2024; 9(1):CNC113.
PMID: 38939826
PMC: 11204175.
DOI: 10.2217/cnc-2023-0012.
A Novel Network Pharmacology Strategy Based on the Universal Effectiveness-Common Mechanism of Medical Herbs Uncovers Therapeutic Targets in Traumatic Brain Injury.
Yu Z, Ding R, Yan Q, Cheng M, Li T, Zheng F
Drug Des Devel Ther. 2024; 18:1175-1188.
PMID: 38645986
PMC: 11032138.
DOI: 10.2147/DDDT.S450895.
Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after TBI.
Huang L, Xia L, Nie T, Cui B, Lu J, Lu F
Exp Mol Med. 2024; 56(1):210-219.
PMID: 38200156
PMC: 10834983.
DOI: 10.1038/s12276-023-01152-4.
Identifying global research trends on inflammation associated with traumatic brain injury by bibliometric and visualized analysis.
Li S, Li F, Fan X, Sun J, Yu Z, Shang H
Heliyon. 2023; 9(12):e22807.
PMID: 38094048
PMC: 10716558.
DOI: 10.1016/j.heliyon.2023.e22807.
Prognostic Value of Plasma Biomarkers S100B and Osteopontin in Pediatric TBI: A Prospective Analysis Evaluating Acute and 6-Month Outcomes after Mild to Severe TBI.
Blackwell L, Wali B, Xiang Y, Alawieh A, Sayeed I, Reisner A
Biomedicines. 2023; 11(8).
PMID: 37626664
PMC: 10452243.
DOI: 10.3390/biomedicines11082167.
Research progress on pleiotropic neuroprotective drugs for traumatic brain injury.
Zhao Q, Li H, Li H, Zhang J
Front Pharmacol. 2023; 14:1185533.
PMID: 37475717
PMC: 10354289.
DOI: 10.3389/fphar.2023.1185533.
Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury.
Eagle S, Puccio A, Agoston D, Soose R, Mancinelli M, Nwafo R
Neurotrauma Rep. 2023; 4(1):404-409.
PMID: 37360545
PMC: 10288300.
DOI: 10.1089/neur.2023.0003.
Efficacy of extracellular vesicles of different cell origins in traumatic brain injury: A systematic review and network meta-analysis.
Yang Z, Liang Z, Lin Y, Lin F, Rao J, Xu X
Front Neurosci. 2023; 17:1147194.
PMID: 37065922
PMC: 10090410.
DOI: 10.3389/fnins.2023.1147194.
